Choate Investment Advisors Edwards Lifesciences Corp Transaction History

Choate Investment Advisors

$3.89 Billion
Q3 2024

A detailed history of Choate Investment Advisors transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Choate Investment Advisors holds 149,981 shares of EW stock, worth $11.1 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

149,981

Previous 152,719 1.79%

Holding current value

$11.1 Million

Previous $14.1 Million 29.84%

% of portfolio

0.25%

Previous 0.37%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$59.7 - $93.78 $163,458 - $256,769	-2,738 Reduced 1.79%	149,981 $9.9 Million
Q2 2024 Aug 08, 2024	SELL	$84.3 - $94.31 $82,529 - $92,329	-979 Reduced 0.64%	152,719 $14.1 Million
Q1 2024 May 07, 2024	BUY	$72.54 - $95.56 $153,567 - $202,300	2,117 Added 1.4%	153,698 $14.7 Million
Q4 2023 Feb 14, 2024	BUY	$61.71 - $77.76 $8.9 Million - $11.2 Million	144,264 Added 1971.63%	151,581 $11.6 Million
Q3 2023 Oct 30, 2023	BUY	$69.28 - $93.38 $67,755 - $91,325	978 Added 15.43%	7,317 $506,000
Q2 2023 Aug 01, 2023	BUY	$81.41 - $94.33 $42,903 - $49,711	527 Added 9.07%	6,339 $597,000
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $2,673 - $3,042	-36 Reduced 0.62%	5,812 $480,000
Q4 2022 Feb 14, 2023	SELL	$68.3 - $87.44 $169,042 - $216,414	-2,475 Reduced 29.74%	5,848 $436,000
Q2 2022 Aug 11, 2022	BUY	$86.5 - $128.27 $333,371 - $494,352	3,854 Added 86.24%	8,323 $791,000
Q1 2022 Apr 29, 2022	SELL	$101.96 - $128.34 $9,890 - $12,448	-97 Reduced 2.12%	4,469 $526,000
Q4 2021 Feb 07, 2022	BUY	$106.37 - $130.68 $14,147 - $17,380	133 Added 3.0%	4,566 $592,000
Q3 2021 Nov 04, 2021	SELL	$102.91 - $122.75 $3,087 - $3,682	-30 Reduced 0.67%	4,433 $502,000
Q2 2021 Jul 30, 2021	SELL	$83.84 - $104.76 $77,971 - $97,426	-930 Reduced 17.24%	4,463 $462,000
Q4 2020 Feb 08, 2021	BUY	$71.69 - $91.23 $16,058 - $20,435	224 Added 4.33%	5,393 $492,000
Q2 2020 Jul 23, 2020	BUY	$57.54 - $76.95 $198,282 - $265,169	3,446 Added 200.0%	5,169 $357,000
Q4 2018 Feb 14, 2019	SELL	$46.41 - $56.94 $5,569 - $6,832	-120 Reduced 6.51%	1,723 $264,000
Q2 2018 Jul 30, 2018	SELL	$42.45 - $51.3 $10,400 - $12,568	-245 Reduced 11.73%	1,843 $268,000
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $75,773 - $81,077	2,088	2,088 $0

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

456M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $45.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Choate Investment Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Choate Investment Advisors with notifications on news.

Account

Choate Investment Advisors Edwards Lifesciences Corp Transaction History